Pages that link to "Q40947112"
Jump to navigation
Jump to search
The following pages link to Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells (Q40947112):
Displaying 10 items.
- Onto better TRAILs for cancer treatment (Q26768160) (← links)
- Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy (Q26772347) (← links)
- Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology. (Q38557486) (← links)
- TRAIL-NP hybrids for cancer therapy: a review. (Q39263297) (← links)
- Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction (Q40994131) (← links)
- Multiwell capillarity-based microfluidic device for the study of 3D tumour tissue-2D endothelium interactions and drug screening in co-culture models (Q41697020) (← links)
- Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes (Q48162156) (← links)
- Lipid Nanoparticles Decorated with TNF-Related Aptosis-Inducing Ligand (TRAIL) Are More Cytotoxic than Soluble Recombinant TRAIL in Sarcoma. (Q53682889) (← links)
- Double-Edged Lipid Nanoparticles Combining Liposome-Bound TRAIL and Encapsulated Doxorubicin Showing an Extraordinary Synergistic Pro-Apoptotic Potential (Q91812392) (← links)
- Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy (Q92756792) (← links)